Opioid Victims Will Get Small Payouts From The Purdue Pharma Settlement People who were addicted to OxyContin or lost loved ones who were addicted to the drug expect very little in compensation from the multibillion-dollar Purdue Pharma bankruptcy settlement.

The Purdue Pharma Deal Would Deliver Billions, But Individual Payouts Will Be Small

  • Download
  • <iframe src="https://www.npr.org/player/embed/1040447650/1041408774" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

NOEL KING, HOST:

People who were addicted to OxyContin or lost their loved ones to the drug will get little in compensation from the Purdue Pharma bankruptcy. Martha Bebinger from member station WBUR in Boston explains why.

MARTHA BEBINGER, BYLINE: Lynn Wencus is one of 138,000 individuals included in the Purdue Sackler settlement. Her son, Jeff, died after an opioid overdose in 2017. To file a claim, Lynn Wencus collected a long, painful thread of receipts for prescriptions, urine tests, doctor's visits, detox and rehab stays and sent them to her lawyer's office.

LYNN WENCUS: I must have mailed them about 200 pages of information that I had through Jeff's almost 10 years of addiction.

BEBINGER: Now that paper trail will be converted to points on a chart in the Purdue Sackler settlement. The points will determine how much Jeff's life was worth.

WENCUS: There's no amount of money that would ease the pain or suffering that he went through, that my family went through. But the chart is a - it's a spit in the face, to be honest with you.

BEBINGER: The maximum award for Jeff's death would be about $40,000. That doesn't touch what the Wencus family spent on Jeff's care. And they'll only get what's left after attorney's fees and outstanding medical claims are paid. Lynn Wencus doesn't know if she'll get anything.

WENCUS: I knew a while ago that the individual claimants were getting thrown aside in this bankruptcy case.

BEBINGER: Thrown aside and assigned little value. Attorneys who review such cases say that $40,000 maximum payment is a fraction of what other drug makers have paid to settle lawsuits. But this settlement was negotiated in bankruptcy court, and that limited what Wencus and others could expect, says Lindsey Simon, who's at the University of Georgia School of Law. In a bankruptcy, there's a fixed pot of money to divide. Individuals argued for a larger share, but lawyers representing the states won. Here's Simon.

LINDSEY SIMON: Do I think that individual claimants were represented? Yes. Do I think the power structure was ultimately in their favor in these negotiations? Probably not.

BEBINGER: The result - individuals will get about 10% of the funds. But many could benefit from money going to the states because it's all supposed to be used to slow the opioid crisis. University of Connecticut law professor Alexandra Lahav says the settlement prioritizes the greater good.

ALEXANDRA LAHAV: To me, it shows an emphasis on, how do we fix what is broken for the future versus people who were already hurt in the past?

BEBINGER: Massachusetts Attorney General Maura Healey, one of the last AGs to sign the deal, says sending most of the money to the states to fund prevention, treatment and recovery means it will reach people who could not or did not sue Purdue.

MAURA HEALEY: So all of those families - and they're the vast, vast majority of families and individuals harmed by the crisis - they're going to be helped through what we were able to do.

BEBINGER: In the end, Lynn Wencus joined the many individuals who voted for the deal, even though she says it's an insult to her son.

WENCUS: If we can take the money that was awarded to the states and do good with it, then another life can be saved so another parent or loved one doesn't have to experience the loss that we have experienced.

BEBINGER: There's a range of views among the individuals who voted yes. Ryan Hampton, who's in recovery from an addiction to opioids, co-chaired a committee that helped negotiate the settlement.

RYAN HAMPTON: Without it, victims would have received nothing. It felt like we were being held hostage.

BEBINGER: Hampton resigned just before the deal was approved and has written a memoir about the bankruptcy proceedings. Hampton only expects to qualify for the minimum payment - $3,500. His treatment bills total nearly half a million dollars. But Hampton says receipts for his Purdue painkillers are long gone. He's angry that is true for many individuals he tried to represent.

HAMPTON: Many families across this country who actually lost loved ones are going to qualify probably for that minimum payout because they're having the exact same issues locating these records. So it was a really high bar to reach.

BEBINGER: Hampton and Wencus say a lot of what bothers them about the settlement seems rooted in discrimination.

WENCUS: There is still so much stigma associated with substance use disorder. And there's still many, many people that believe it's not a disease. It's a choice.

BEBINGER: That's a perception money flowing into treatment and prevention could help correct. The first small checks could reach individuals late next year if the Purdue settlement survives appeals.

For NPR News, I'm Martha Bebinger in Boston.

(SOUNDBITE OF BLOCKHEAD'S "INSOMNIAC OLYMPICS")

Copyright © 2021 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by an NPR contractor. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.